Remote Monitoring to Optimize Heart Failure Treatment
Part of Heart & circulation clinical trials.
This study tests whether a wearable device that monitors your heart and transmits data to your doctor can help optimize your heart failure medications after hospitalization. The goal is to prevent future hospital visits and improve your health by keeping closer tabs on how your body responds to treatment adjustments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Recently hospitalized for acute heart failure with fluid buildup in the lungs (shown on chest X-ray)
- Blood pressure at least 100 mmHg and heart rate at least 60 beats per minute in the 24 hours before enrollment
- Specific blood test results (NT-proBNP >1500 at admission and >1000 three days later) showing persistent congestion
- Currently on less than optimal doses of heart failure medications (ACE inhibitors, ARBs, beta-blockers, or aldosterone antagonists)
- Able to wear an adhesive patch device on your skin without allergies or skin damage
- No plans for a heart transplant, mechanical heart pump, or wearable defibrillator in the next year
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a home monitoring system called Cardiosignal to help manage heart failure after an emergency room visit. It may help doctors adjust your treatments to keep you healthier at home.
This study looks at how a small monitor inside the blood vessel to the lungs helps manage heart failure. It aims to improve care for people with advanced heart failure.
This trial is testing a special monitor (BIOMONITOR) that tracks your heart function and sends data wirelessly to your doctor. It aims to help manage heart failure by catching early signs of trouble so you can get treatment sooner.
This study tests whether a special monitoring system in your heart device (called HeartLogic) can help detect early warning signs of heart failure getting worse. It uses wireless check-ins to track your condition at home and alert your doctor if you need help.
This trial tests whether remote monitoring of your implanted heart device can help your doctors better manage your heart failure. It is for people with certain types of pacemakers or defibrillators who are willing to share their device data remotely.
This study looks at how “personalized” (precision) treatment planning for heart failure may work, using results from heart imaging (echocardiogram) or a blood test called B-type natriuretic peptide. You may join if you have heart failure and can follow frequent study check-ins.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.